Skip to main content
SpringerLink
Log in

Specific active immunotherapy for primary melanoma: Experience with 5399 Patients

  • Abstracts Accepted for Plenary and Parallel Sessions
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

  1. Surgery, Duke University Medical Center, Durham, NC

    R. White, P. Mosca, W. Stanley, J. Johnson, D. S. Tyler & H. F. Seigler

Authors
  1. R. White
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Mosca
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. Stanley
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. S. Tyler
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. F. Seigler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

White, R., Mosca, P., Stanley, W. et al. Specific active immunotherapy for primary melanoma: Experience with 5399 Patients. Annals of Surgical Oncology 11 (Suppl 2), S59–S60 (2004). https://doi.org/10.1007/BF02523997

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02523997

Keywords

Search

Navigation